Literature DB >> 28363765

Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: Relevance and implications for therapy.

Amedeo Minichino1, Agata Ando'2, Marta Francesconi3, Adriana Salatino2, Roberto Delle Chiaie4, Kristin Cadenhead5.   

Abstract

Evidence suggests that obesity and overweight may be associated with severe brain structural abnormalities and poor cognitive and functional outcomes in the general population. Despite these observations and the high prevalence of weight gain abnormalities in patients with psychosis spectrum disorders (PSDs), no studies have investigated the impact that these metabolic disturbances may have on brain structures and development in the earliest stages of PSDs. In the present review we shed light on the association between weight gain and brain structural abnormalities that may affect the course of illness in drug-naïve FEPs. Given the lack of studies directly investigating this issue, we firstly identified and critically evaluated the literature assessing weight gain abnormalities and gray or white matter (GM, WM) volumes (either globally or in specific regions of interest) in otherwise healthy obese/overweight adolescents and young adults. We then compared the results of this systematic review with those of two recent meta-analysis investigating GM and WM abnormalities in drug-naïve FEPs. Weight gain in otherwise healthy subjects was consistently associated with frontal and temporal GM atrophy and with reduced integrity of WM in the corpus callosum. Of relevance, all these brain regions are affected in drug-naïve FEPs, and their integrity is associated with clinical, cognitive and functional outcomes. The underlying mechanisms that may explain the association between weight gain, adiposity, and brain damage in both healthy subjects and drug-naïve FEPs are widely discussed. On the basis of this knowledge, we tried: a) to deduce an integrative model for the development of obesity in psychosis spectrum disorders; b) to identify the key vulnerability factors underlying the association between weight gain and psychosis; c) to provide information on new potential targets of intervention.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain structure; Neuroimaging; Obesity; Overweight; Psychosis; Visceral adiposity

Mesh:

Year:  2017        PMID: 28363765     DOI: 10.1016/j.pnpbp.2017.03.020

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Who should be "controls" in studies on the neurobiology of psychiatric disorders?

Authors:  Patricia Boksa; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

2.  Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis.

Authors:  Amedeo Minichino; Morwenna Senior; Natascia Brondino; Sam H Zhang; Beata R Godwlewska; Philip W J Burnet; Andrea Cipriani; Belinda R Lennox
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

3.  Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium.

Authors:  Kristin S Cadenhead; Amedeo Minichino; Skylar Kelsven; Jean Addington; Carrie Bearden; Tyrone D Cannon; Barbara A Cornblatt; Dan Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Jeff Yao
Journal:  Schizophr Res       Date:  2018-09-22       Impact factor: 4.939

4.  Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal.

Authors:  Ricardo Coentre; Pedro Levy; Carlos Góis; Maria Luísa Figueira
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

5.  Gray matter reduction in bilateral insula mediating adverse psychiatric effects of body mass index in schizophrenia.

Authors:  Hui Wu; Guochao Dai; Muyeseer Aizezi; Juan Tang; Ke Zou; Yuhua Wu; Xiaoli Wu
Journal:  BMC Psychiatry       Date:  2022-10-11       Impact factor: 4.144

6.  Higher Body-Mass Index and Lower Gray Matter Volumes in First Episode of Psychosis.

Authors:  Marián Kolenič; Filip Španiel; Jaroslav Hlinka; Martin Matějka; Pavel Knytl; Antonín Šebela; Jiří Renka; Tomas Hajek
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.